Argus Research Initiates Equity Research Report Coverage on AzurRx BioPharma, Inc. (NasdaqCM: AZRX)
AzurRx BioPharma, Inc. (AZRX)
Last azurrx biopharma, inc. earnings: 11/14 04:31 pm
Check Earnings Report
US:NASDAQ Investor Relations:
azurrx.com/index.php/investors/investor-relations
Company Research
Source: GlobeNewswire
NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) -- Argus Research, an independent investment research firm, has launched Equity Research Report coverage on AzurRx BioPharma, Inc. (NasdaqCM: AZRX) Click here to view Full Argus Report. Highlights, as conveyed by Argus Analyst Steve Silver, include: COMPANY HIGHLIGHTS AZRX: Supporting Patients with Pancreas-Mediated Digestion Disorders In our view, AzurRx’s lead product candidate, MS1819, provides a potential alternative to the current standard-of-care treatment for patients with gastrointestinal disorders originating in the pancreas. The current standard of care is a porcine-based pancreatic enzyme replacement therapy (PERT), which exposes patients to the risk of infection, allergies, and potential adverse events when used at high doses; it and carries a high pill burden that can lead to patient noncompliance.In December 2019 and January 2020, AzurRx raised $6.9 million in a private placement. In additi
Show less
Read more
Impact Snapshot
Event Time:
AZRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZRX alerts
High impacting AzurRx BioPharma, Inc. news events
Weekly update
A roundup of the hottest topics